Are You Looking for a Top Momentum Pick? Why Bayer Aktiengesellschaft (BAYRY) is a Great ChoiceZacks Investment Research • 02/10/26
Here's Why Bayer Aktiengesellschaft (BAYRY) is a Strong Momentum StockZacks Investment Research • 02/09/26
Bayer Aktiengesellschaft (BAYRY) Discusses OCEANIC-STROKE Phase III Results and Asundexian in Secondary Stroke Prevention TranscriptSeeking Alpha • 02/06/26
Bayer's Asundexian Shows 26% Stroke Reduction in Late-Stage StudyZacks Investment Research • 02/06/26
Bayer's Asundexian Demonstrated a Substantial 26% Reduction in Stroke After a Non-Cardioembolic Ischemic Stroke or High-Risk Transient Ischemic Attack, With No Increase in ISTH Major Bleeding Versus PlaceboBusiness Wire • 02/05/26
Bayer Teams Up with Former Professional Quarterback Tony Romo on ‘Highlights REAL' CampaignBusiness Wire • 01/29/26
Bayer Investing More Than $45M CAD to Build World-Class Canola Research and Development Facility in CanadaBusiness Wire • 01/27/26
Bayer to Present Results From Phase III OCEANIC-STROKE Study of Asundexian in Secondary Stroke PreventionBusiness Wire • 01/27/26
Bayer Aktiengesellschaft (BAYRY) is a Top-Ranked Value Stock: Should You Buy?Zacks Investment Research • 01/26/26
Bayer Aktiengesellschaft (BAYRY) is a Great Momentum Stock: Should You Buy?Zacks Investment Research • 01/22/26
Bayer Shares Jump as Supreme Court Agrees to Review Key Roundup CaseZacks Investment Research • 01/20/26
Bayer and Vanderbilt University Medical Center to Advance Treatments for Cardiovascular and Kidney DiseasesBusiness Wire • 01/20/26
Supreme Court to hear Bayer's appeal to block thousands of Roundup weedkiller lawsuitsNew York Post • 01/16/26
Bayer welcomes the U.S. Supreme Court decision to review the Durnell case in the Roundup™ litigationBusiness Wire • 01/16/26
Bayer Aktiengesellschaft (BAYRY) Presents at 44th Annual J.P. Morgan Healthcare Conference TranscriptSeeking Alpha • 01/13/26